Form D · Other Technology
Zurex PharmAgra, LLC
Middleton, WI · CIK 0001581618
Offering snapshot reported Jul 17, 2013 · SEC filing
- Reported sold
- $846K Offering amount: $1.22M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 3, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 17, 2013 | Initial | $846,458 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-199828
Source: Form D, filed Jul 17, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nicholas C. Babson | Director |
| Carmine J Durham | Director, Executive |
| Alexander M. Kasper | Executive |
| Andrew Morgan | Executive |
| Michael C. Pawlak | Director, Executive |
| Jason Smith | Director |
| Gary Tauchen | Director |
| Robert B Truitt | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
2113 Eagle Drive
Middleton, WI, 53562
Middleton, WI, 53562